Softbank Vision FUND (aiv M1) L.P., 10% Owner at Vir Biotechnology, Inc. (VIR), sold 418,558 shares at $27.65 ($11.6M) on 2022-11-30, disclosed to the SEC on 2022-12-02.
Open-market sale of $11.6M VIR by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $27.65 | 102,291 | $2.8M | 24.3% |
| 2 | $27.65 | 102,291 | $2.8M | 24.3% |
| 3 | $28.17 | 63,662 | $1.8M | 15.4% |
| 4 | $28.17 | 63,662 | $1.8M | 15.4% |
| 5 | $27.39 | 40,276 | $1.1M | 9.5% |
| 6 | $27.39 | 40,276 |
| $1.1M |
| 9.5% |
| 7 | $28.08 | 6,100 | $171K | 1.5% |
| Total | $27.76 avg | 418,558 | $11.6M | 100% |
| Filing → |
| VIR | SELL | 2023-07-05 | $18K | — | Filing → |
| COMP | SELL | 2023-06-09 | $55.4M | — | Filing → |
| VIR | SELL | 2023-04-18 | $1.0M | — | Filing → |